Skip to search formSkip to main contentSkip to account menu

Phosphatidylcholine Ab.IgG:PrThr:Pt:Ser:Ord

Known as: Fosfatidilcolina IgG:Propiedad utilizada para términos LOINC cuyos resultados estan en escala categórica ordenada.:Punto temporal:Suero:Ord, Phosphatidylcholine anticorps IgG [Arbitraire/Volume] Sérum ; Qualitatif, Phosphatidylcholine IgG Ab [Presence] in Serum 
National Institutes of Health

Related topics

Related topics

5 relations
AntibodiesBlood coagulation testsImmunoglobulin GPhosphatidylcholines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Protective Effect of Silybin-phosphatidylcholine Compound on Acute Liver Injury Induced by CHCl_3 in Mice
Objective To investigate the protective effect of silybin-phosphatidylcholine compound(SPC)on acute liver injury induced by CHCl3… 
2008
2008
Experimental and clinical study of silibin-phosphatidylcholine compound on fatty liver disease
Objective To investigate the effect of silybin-phosphatidylcholine compound(SPC)on the development of fatty liver in rats and… 
2007
2007
Protective effects of breviscapine phosphatidylcholine complex against cerebral ischemia reperfusion injury in rats
Objective To study the protective effects of breviscapine phosphatidylcholine complex(Ber-PC) against brain injury in rats… 
2006
2006
Protective Effect of Silybin-Phosphatidylcholine Compound on Acute Liver Damage Induced by Alpha-Naph-thylisothiocyanate in Mice
Objective To observe the protective effect of silybin-phosphatidylcholine compound(SPC) on acute liver damage induced by alpha… 
2004
2004
Protective effects of silybin-phosphatidylcholine compound on acute liver damage in mice induced by CCl_4
Objective: To study the protective and therapeutic effects of silybin-phos-phatidylcholine compound (SPC) on acute liver damage… 
1999
1999
Unsaturated fatty acid-activated protein kinase (PKx) from goat testis cytosol.
Highly Cited
1995
Highly Cited
1995
Paramagnetic polymerized liposomes as new recirculating MR contrast agents
We describe a well‐tolerated blood pool contrast agent with extended reclrculatory half‐life based on paramagnetic polymerized… 
1989
1989
Reduction of hyperlipidemia with 3-sn-polyenyl-phosphatidylcholine in dialysis patients.
Hyperlipidemia is of particular concern in dialysis patients due to the high incidence of ischemic cardiovascular complications… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)